Photodynamic Therapy 2021
Photodynamic therapy (PDT) is a light-based photochemistry process. The illumination of a photoactivatable molecule (also called photosensitizer) with visible or near infrared light produces reactive oxygen toxic species to destroy tumor cells. This treatment modality leads to highly targeted action...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_93784 | ||
| 005 | 20221117 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20221117s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-5351-1 | ||
| 020 | |a 9783036553511 | ||
| 020 | |a 9783036553528 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-5351-1 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a MJCL |2 bicssc | |
| 100 | 1 | |a Mordon, Serge |4 edt | |
| 700 | 1 | |a Mordon, Serge |4 oth | |
| 245 | 1 | 0 | |a Photodynamic Therapy 2021 |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (238 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Photodynamic therapy (PDT) is a light-based photochemistry process. The illumination of a photoactivatable molecule (also called photosensitizer) with visible or near infrared light produces reactive oxygen toxic species to destroy tumor cells. This treatment modality leads to highly targeted actions, because reactive oxygen species are produced only where light is applied. Light is not harmful, nor is the photoactivable molecule. Only the combination of three elements (photosensitizer, oxygen, and light) is required to induce photo-oxidation reactions. PDT has proven to be a promising modality in many medical applications including cutaneous condition, infectious diseases, and various cancers at different stages. This book is a reprint of the Special Issue "Photodynamic Therapy 2021" that was published in Pharmaceuticals. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Oncology |2 bicssc | |
| 653 | |a β-mannose-conjugated chlorin e6 | ||
| 653 | |a talaporfin sodium | ||
| 653 | |a glioblastoma | ||
| 653 | |a U251 | ||
| 653 | |a photodynamic therapy | ||
| 653 | |a PDT | ||
| 653 | |a laser | ||
| 653 | |a ceramics | ||
| 653 | |a bacteria | ||
| 653 | |a decontamination | ||
| 653 | |a cross-linking agents | ||
| 653 | |a fluorescent dyes | ||
| 653 | |a oxidation reduction | ||
| 653 | |a photochemistry | ||
| 653 | |a photosensitizing agents | ||
| 653 | |a protein conformation | ||
| 653 | |a Rose Bengal | ||
| 653 | |a protoporphyrin IX | ||
| 653 | |a pyropheophorbide-a | ||
| 653 | |a Photofrin® | ||
| 653 | |a absorption | ||
| 653 | |a fluorescence | ||
| 653 | |a singlet oxygen | ||
| 653 | |a 5-aminolevulinic acid | ||
| 653 | |a 5-ALA | ||
| 653 | |a dALA | ||
| 653 | |a δALA | ||
| 653 | |a PpIX | ||
| 653 | |a actinic keratosis | ||
| 653 | |a illumination time | ||
| 653 | |a incubation time | ||
| 653 | |a dental implant | ||
| 653 | |a peri-implantitis | ||
| 653 | |a photoantimicrobial chemotherapy | ||
| 653 | |a methylene blue | ||
| 653 | |a chitosan | ||
| 653 | |a curcumin | ||
| 653 | |a natural photosensitizer | ||
| 653 | |a skin cancer treatment | ||
| 653 | |a squamous cell carcinoma | ||
| 653 | |a melanoma | ||
| 653 | |a normal keratinocytes | ||
| 653 | |a liposomes | ||
| 653 | |a glioblastoma multiforme | ||
| 653 | |a AGuIX® | ||
| 653 | |a terbium | ||
| 653 | |a gadolinium | ||
| 653 | |a X-ray-induced photodynamic therapy | ||
| 653 | |a chemotherapy | ||
| 653 | |a zinc (II) phthalocyanine | ||
| 653 | |a tin complex | ||
| 653 | |a methyl aminolevulinate | ||
| 653 | |a riboflavin | ||
| 653 | |a ultraviolet radiation | ||
| 653 | |a skin tumors | ||
| 653 | |a prophylactic treatment | ||
| 653 | |a hairless mice | ||
| 653 | |a photothermal therapy | ||
| 653 | |a radiation therapy | ||
| 653 | |a immunotherapy | ||
| 653 | |a immune checkpoint inhibition | ||
| 653 | |a murine models | ||
| 653 | |a clinical trials | ||
| 653 | |a programmed death-ligand 1 protein (PD-L1) | ||
| 653 | |a magnetic nanoparticles | ||
| 653 | |a peptide-imprinted polymer | ||
| 653 | |a photoinactivation | ||
| 653 | |a resistance | ||
| 653 | |a antimicrobial agents | ||
| 653 | |a SSTI | ||
| 653 | |a MDR | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/6212 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/93784 |7 0 |z DOAB: description of the publication |